Plain-English translation of NCT07270172 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →The MICRON study is testing whether a more aggressive approach to managing type 1 diabetes—using three specific medications (semaglutide, sotagliflozin, and finerenone) along with stricter blood pressure and cholesterol targets—can reduce the strain on your heart and kidneys compared to standard care. Researchers will use special imaging scans to measure how much oxygen your heart and kidneys are using, which can indicate how hard these organs are working.
People with type 1 diabetes often develop heart and kidney problems over time, and the current standard treatment may not be enough to fully protect these vital organs. This study wants to find out whether the more intensive approach can better protect your heart and kidneys and reduce the damage diabetes can cause.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be assigned to either the intensive treatment group or the standard care group (both continuing what you're already doing in the larger Steno 1 study). You will visit the clinic at the start, after 6 months, and after 24 months for special imaging scans of your heart and kidneys, blood and urine tests, and body measurements. The imaging scans use advanced PET technology to measure how much oxygen your heart and kidneys are using—a sign of how stressed these organs are.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Denmark